Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001372514-23-000034

Chief Development Officer acquired 15,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Daniels Eric Joseph · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-03 Grant or award : show line 1 in the form +15,600 25,838 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-03 Grant or award : show line 2 in the form Stock Option (right to buy) +10,400 10,400 D
Loading xslF345X03/wf-form4_167823807843002.xml…